JPMORGAN CHASE & CO - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$40,777,000
+152.8%
1,480,611
+51.4%
0.01%
+150.0%
Q1 2021$16,129,000
+17.0%
978,061
+30.7%
0.00%0.0%
Q4 2020$13,788,000
+63.5%
748,128
+20.8%
0.00%
+100.0%
Q3 2020$8,434,000
+76.7%
619,245
+132.5%
0.00%0.0%
Q2 2020$4,772,000
+306.1%
266,307
+126.0%
0.00%
Q1 2020$1,175,000
+173.9%
117,855
+123.9%
0.00%
Q4 2019$429,000
+300.9%
52,637
+386.5%
0.00%
Q3 2019$107,000
+2.9%
10,819
+34.1%
0.00%
Q2 2019$104,000
+42.5%
8,068
+12.4%
0.00%
Q1 2019$73,000
+284.2%
7,175
+186.4%
0.00%
Q4 2018$19,000
-17.4%
2,505
+10.3%
0.00%
Q3 2018$23,0002,2710.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders